AIM Concept Integration
3rd Year MBBS
Blood and Immunology
Blood and Immunology
Hemolytic Anemias and Hemoglobinopathies
Connect the major mechanisms, morphology, diagnostic clues and management principles for rapid revision.
1. THE TOPIC IN ONE CONNECTED FLOW
Hemolytic anemias share one final problem: red cells are destroyed faster than the marrow can replace them. The important distinction is why the RBC becomes vulnerable. A membrane defect, abnormal hemoglobin, enzyme deficiency, acquired complement sensitivity or immune coating produces a characteristic pattern of morphology, hemolysis and diagnostic testing.
RBC abnormality
Inherited or acquired defect
→
Core mechanism
Membrane instability, Hb abnormality, oxidative injury, complement or antibody
→
RBC change
Spherocyte, sickle cell, target cell, bite cell or complement-sensitive RBC
→
Hemolysis
Extravascular or intravascular RBC destruction
→
Laboratory response
Reticulocytosis, ↑ bilirubin/LDH, ↓ haptoglobin
→
Disease-specific diagnosis
EMA/DAT, Hb analysis, G6PD assay or PNH flow cytometry
How the major disorders fit into the flow
Hereditary spherocytosis: membrane-protein defect → membrane loss → spherocyte → splenic trapping → extravascular hemolysis.
Sickle cell anemia: β-globin mutation → HbS polymerization during deoxygenation → sickling → hemolysis + microvascular obstruction.
Thalassemia: reduced globin-chain synthesis → chain imbalance → ineffective erythropoiesis + abnormal circulating RBCs → anemia and hemolysis.
G6PD deficiency: reduced NADPH/glutathione protection → oxidative Hb injury → Heinz bodies → splenic “bites” → hemolysis.
PNH: acquired PIGA-mutant stem-cell clone → loss of GPI-linked CD55/CD59 → complement sensitivity → intravascular hemolysis.
Immune hemolysis: antibody ± complement binding → macrophage clearance or complement injury → warm or cold immune hemolytic anemia.
2. KEY CLINICAL CONNECTIONS
Morphology → Mechanism → Diagnosis
Spherocytes
→
reduced membrane surface area
→
hereditary spherocytosis or warm immune hemolysis
→
reduced membrane surface area
→
hereditary spherocytosis or warm immune hemolysis
DAT negative
→
supports hereditary spherocytosis;
DAT positive
→
supports immune hemolysis.
→
supports hereditary spherocytosis;
DAT positive
→
supports immune hemolysis.
Hemoglobin Disorder → Clinical Effect
Deoxygenated HbS polymerization
→
rigid sickled cells
→
hemolysis + vaso-occlusion.
→
rigid sickled cells
→
hemolysis + vaso-occlusion.
Increased HbF
→
reduced HbS polymerization
→
fewer sickling-related complications.
→
reduced HbS polymerization
→
fewer sickling-related complications.
Microcytosis → Investigation → Management
Marked microcytosis with adequate iron stores
→
consider thalassemia
→
Hb analysis/genetic assessment where required.
→
consider thalassemia
→
Hb analysis/genetic assessment where required.
Severe transfusion-dependent disease
→
repeated transfusion
→
iron loading
→
chelation and monitoring.
→
repeated transfusion
→
iron loading
→
chelation and monitoring.
3. AIM HIGH-YIELD INTEGRATION REVIEW
⭐ Hereditary spherocytosis: membrane loss → reduced deformability → splenic destruction; spherocytes plus a negative DAT favor the inherited membrane disorder.
⭐ Sickle cell anemia: deoxygenated HbS polymerizes → sickling → both chronic hemolysis and vaso-occlusion; Hb electrophoresis/HPLC identifies the abnormal hemoglobin.
Functional asplenia: repeated splenic infarction in sickle cell disease → Howell–Jolly bodies and increased vulnerability to serious infection.
⭐ β-Thalassemia: deficient β-chain synthesis → excess unpaired α chains → ineffective erythropoiesis and hemolysis; severe disease produces marrow expansion and transfusion dependence.
α-Thalassemia: severity rises as more α-globin genes are affected; three-gene loss produces HbH, while four-gene loss produces Hb Bart’s during fetal life.
⭐ G6PD deficiency: inadequate NADPH → reduced glutathione protection → oxidative Hb precipitation → Heinz bodies and bite cells; testing during an acute attack may underestimate deficiency.
PNH: acquired PIGA mutation → deficient CD55/CD59 → complement-mediated intravascular hemolysis; flow cytometry demonstrates the abnormal GPI-deficient clone.
Immune hemolysis: warm IgG disease favors splenic extravascular destruction, whereas cold IgM disease activates complement and may produce hepatic clearance or intravascular lysis.
AIM Exam Trap: Spherocytes are not specific for hereditary spherocytosis. Spherocytes + negative DAT favor hereditary spherocytosis, while spherocytes + positive DAT favor immune hemolytic anemia.